ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome.
Huang S, Laoukili J, Epping MT, Koster J, Hölzel M, Westerman BA, Nijkamp W, Hata A, Asgharzadeh S, Seeger RC, Versteeg R, Beijersbergen RL, Bernards R.
Huang S, et al. Among authors: epping mt.
Cancer Cell. 2009 Apr 7;15(4):328-40. doi: 10.1016/j.ccr.2009.02.023.
Cancer Cell. 2009.
PMID: 19345331
Free PMC article.